L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Revenue

L&K Biomed had revenue of 8.89B KRW in the quarter ending March 31, 2025, a decrease of -2.55%. This brings the company's revenue in the last twelve months to 35.86B, up 14.58% year-over-year. In the year 2024, L&K Biomed had annual revenue of 36.09B with 20.69% growth.

• Revenue (ttm): 35.86B
• Revenue Growth: +14.58%
• P/S Ratio: 3.26
• Revenue / Employee: 394.06M
• Employees: 60
• Market Cap: 116.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.09B	6.19B	20.69%
Dec 31, 2023	29.90B	10.14B	51.28%
Dec 31, 2022	19.77B	4.39B	28.59%
Dec 31, 2021	15.37B	-3.98B	-20.58%
Dec 31, 2020	19.36B	-7.22B	-27.16%